Hormone replacement therapy in women with liver disease

J O'Donohue, John O’Donohue, Roger A. Williams, R Williams
British journal of obstetrics and gynaecology · 1997 · vol. 104(1) , pp. 1–3 · doi:10.1111/j.1471-0528.1997.tb10638.x · PMID:8988686 · W2032212417
Other OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-14 ⓘ

The provided text lacks an abstract and does not describe any research findings related to endometriosis or adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Estrogen Replacement Therapy Estrogen Replacement Therapy Liver Diseases Bone Diseases Bone Diseases Cholestasis Cholestasis Female Follow-Up Studies Humans Liver Diseases Liver Diseases Patient Selection Risk Factors

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (27)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T22:00:02.201502+00:00
License: CC0 · commercial use OK